Pediatrics

(SLC-031) Adverse events of special interest (AESI) Following COVID-19 Vaccination in Children and Adolescents Aged 5–17 Years: A Retrospective Cohort Study in South Korea

(SLC-028) Application of Pharmacokinetic Models in Real-World Data to Estimate Therapeutic Concentration in Pediatric Pharmacoepidemiology

(SLC-026) Association between antibiotic exposure and response to treatment of juvenile idiopathic arthritis

(SLC-027) Development and Validation of a Nomogram for Predicting the Risk of Refractory Mycoplasma Pneumoniae Pneumonia in Children

(SLC-030) Estimating Chronic Kidney Disease Prevalence in the Pediatric Population in the United States Using Clinical Electronic Health Records (EHR) database

(SLC-025) High-Risk Medications in Pediatric Dentistry: Patterns, Outcomes, and Clinical Implications

(B-244) Identification of Neonatal Jaundice from Automated Electronic Health Record Data

(B-245) Pediatric Acute Bacterial Skin and Soft Tissue Infections: Incidence and Antibiotic Prescriptions

(SLC-029) Predicting the Probability of Spontaneous Patent Ductus Arteriosus Closure to Inform Clinical Treatment Decisions for Preterm Infants

(SLC-032) Prenatal Exposure to Antiseizure Medications and Risk of ADHD in Children